$19.29
-$0.37
(-1.88%)
Quote as of 4:00 PM EST on 02/10/12
Auxilium Pharmaceuticals, Inc.
NASDAQ:AUXL
Leerink's biotech and pharmaceuticals analysts hold a conference call
Auxilium announces appointments to enhance leadership team
Auxilium Announces Appointments to Enhance Leadership Team
Auxilium removed from short-term buy list at Deutsche Bank
Auxilium recieves cautious assessment for Xiaflex, says Leerink
Auxilium initiates phase Ib trial of Xiaflex treatment for cellulite
Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX® Phase Ib Cellulite Study
Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX® Phase Ib Cellulite Study
RBC Capital Upgrades Auxilium Pharmaceuticals (AUXL) to Outperform
Auxilium upgraded to Outperform from Sector Perform at RBC Capital
Collins Stewart hosts events in conjunction with JP Morgan Healthcare Conference
Auxilium Pharmaceuticals (AUXL) Provides FY11 Revenue Update
Auxilium management to meet with Collins Stewart
Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Summer Street's biotech analyst research team to hold a conference call
RBC Capital's biotechnology analyst holds a conference call
Summer Street's chief scientific officer holds a conference call on Auxilium
Auxilium sees 2011 revenue $254M-$271M vs. consensus $264.14M
People news: Auxilium Pharmaceuticals and Essentialis
7 Stocks Rising on Huge Volume
Auxilium appoints Adrian Adams as CEO
Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and President
Auxilium announces first patient dosed in XIAFLEX study for frozen shoulder
Auxilium management to meet with Jefferies
Auxilium Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
Auxilium Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
Auxilium management to meet with Collins Stewart
Auxilium Pharmaceuticals Inc. Reports Operating Results (10-Q)
Auxilium Pharmaceuticals Inc. (AUXL) CFO James E Fickenscher buys 1,610 Shares
Auxilium says TRiUS data suggest Testim improved sexual function
TRiUS Data Suggests That Testim® Significantly Improved Sexual Function in Hypogonadal Men
Auxilium announces payment rates for 2012 have been released
Jefferies Cuts Price Targets on Auxilium Pharmaceuticals (AUXL) As Xiaflex Sales Remain Weak
Auxilium Pharmaceuticals revenues rise 24%
Auxilium Pharmaceuticals - Revenues rose 24.4% yea..
